HORIZON PHARMA PLC's ticker is HZNPXXXX and the CUSIP is G4617B105. A total of 182 filers reported holding HORIZON PHARMA PLC in Q3 2017. The put-call ratio across all filers is 0.37 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $6,388,000 | +40.8% | 241,692 | +4.1% | 0.07% | +28.3% |
| Q4 2018 | $4,536,000 | +132.1% | 232,162 | +132.7% | 0.05% | +130.4% |
| Q3 2018 | $1,954,000 | +82.4% | 99,771 | +54.2% | 0.02% | +64.3% |
| Q2 2018 | $1,071,000 | +169.1% | 64,700 | +131.1% | 0.01% | +133.3% |
| Q1 2018 | $398,000 | -75.9% | 28,000 | -75.3% | 0.01% | -79.3% |
| Q4 2017 | $1,654,000 | +13.1% | 113,256 | -1.8% | 0.03% | +3.6% |
| Q3 2017 | $1,462,000 | +484.8% | 115,332 | +581.0% | 0.03% | +300.0% |
| Q1 2017 | $250,000 | -11.3% | 16,936 | -3.0% | 0.01% | -41.7% |
| Q4 2016 | $282,000 | -53.5% | 17,456 | -47.9% | 0.01% | -70.0% |
| Q3 2016 | $607,000 | +32.5% | 33,500 | +45.0% | 0.04% | -64.9% |
| Q3 2015 | $458,000 | -85.3% | 23,100 | -74.3% | 0.11% | -88.7% |
| Q2 2015 | $3,120,000 | – | 89,800 | – | 1.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Broadfin Capital, LLC | 5,664,219 | $83,717,000 | 10.14% |
| Consonance Capital Management LP | 6,218,903 | $91,915,000 | 9.63% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 10,944,988 | $161,767,000 | 6.24% |
| Rhenman & Partners Asset Management AB | 1,751,322 | $25,885,000 | 4.10% |
| SCOPIA CAPITAL MANAGEMENT LP | 9,686,262 | $143,163,000 | 2.64% |
| ARMISTICE CAPITAL, LLC | 850,000 | $12,563,000 | 2.59% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 2,959,258 | $43,738,000 | 2.40% |
| Proxima Capital Management, LLC | 246,311 | $3,640,000 | 2.22% |
| Beach Point Capital Management LP | 522,898 | $7,728,000 | 2.18% |
| GRAYBILL WEALTH MANAGEMENT, LTD. | 165,260 | $2,443,000 | 1.94% |